Igor's call, in full

What started as a movement to heal PTSD, depression, and addiction has become a boardroom land grab. I forecast the global psychedelic-medicine market hits $10 billion by 2027-28, as MDMA, psilocybin, and lab-made variants move from underground ceremonies to corporate patents. The tension is real. Treatment price tags of $5,000 to $10,000 risk turning healing into a luxury for the wealthy rather than a lifeline for those who need it most. Oregon and Colorado are rolling out therapeutic psilocybin; Lykos had its MDMA-assisted PTSD treatment rejected by an FDA advisory panel in 2024; Usona is pushing psilocybin through Phase 3 under breakthrough-therapy status. Psychedelics could transform mental health for millions, or become just another overhyped asset class. Right now it is a coin toss, and the money is racing ahead of the guardrails.

Adjacent calls

The global longevity economy, products and services for people over 50, reaches $20 trillion annually by 2030.On trackI named gen z the "screenagers" in the early 2000s, a generation raised inside the algorithm that would be shaped and harmed by it. The 2026 data is the landing.Landed · verifiedLive sports grows into a $10 trillion attention economy by 2050.On track

Ask Igor your own question. 5 free.